» Articles » PMID: 32567396

Nutritional Intervention in Chronic Pain: an Innovative Way of Targeting Central Nervous System Sensitization?

Overview
Publisher Informa Healthcare
Specialty Pharmacology
Date 2020 Jun 23
PMID 32567396
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Few treatment programs for chronic pain nowadays take a dietary pattern or adipose status into account.

Areas Covered: An important role of neuroinflammation in chronic pain is now well established, at least in part due to increased central nervous system glial activation. Based on preclinical studies, it is postulated that the interaction between nutrition and central sensitization is mediated via bidirectional gut-brain interactions. This model of diet-induced neuroinflammation and consequent central sensitization generates a rationale for developing innovative treatments for patients with chronic pain. Methods: An umbrella approach to cover the authors' expert opinion within an evidence-based viewpoint.

Expert Opinion: A low-saturated fat and low-added sugar dietary pattern potentially decreases oxidative stress, preventing Toll-like receptor activation and subsequent glial activation. A low-saturated fat and low-added sugar diet might also prevent afferent vagal nerve fibers sensing the pro-inflammatory mediators that come along with a high-(saturated) fat or energy-dense dietary pattern, thereby preventing them to signal peripheral inflammatory status to the brain. In addition, the gut microbiota produces polyamines, which hold the capacity to excite N-methyl-D-aspartate receptors, an essential component of the central nervous system sensitization. Hence, a diet reducing polyamine production by the gut microbiota requires exploration as a therapeutic target for cancer-related and non-cancer chronic pain.

Citing Articles

Subgroup Characteristics of Middle-Aged and Older Women with Chronic Low Back Pain by Multiple Factors: A Hierarchical Cluster Analysis.

Miyachi R, Nishimura T, Noguchi M, Goda A, Takeda H, Takeshima E J Funct Morphol Kinesiol. 2025; 10(1.

PMID: 39846671 PMC: 11755572. DOI: 10.3390/jfmk10010030.


Role of Nutrition in the Management of Patients with Chronic Musculoskeletal Pain.

Cuomo A, Parascandolo I J Pain Res. 2024; 17:2223-2238.

PMID: 38947129 PMC: 11214565. DOI: 10.2147/JPR.S456202.


A Personalized Mediterranean Diet Improves Pain and Quality of Life in Patients with Fibromyalgia.

Casini I, Ladisa V, Clemente L, Delussi M, Rostanzo E, Peparini S Pain Ther. 2024; 13(3):609-620.

PMID: 38683449 PMC: 11111631. DOI: 10.1007/s40122-024-00598-2.


Exploring the association between dietary Inflammatory Index and chronic pain in US adults using NHANES 1999-2004.

Qing L, Zhu Y, Yu C, Zhang Y, Ni J Sci Rep. 2024; 14(1):8726.

PMID: 38622145 PMC: 11018766. DOI: 10.1038/s41598-024-58030-w.


Gut dysbiosis in patients with chronic pain: a systematic review and meta-analysis.

Goudman L, Demuyser T, Pilitsis J, Billot M, Roulaud M, Rigoard P Front Immunol. 2024; 15:1342833.

PMID: 38352865 PMC: 10862364. DOI: 10.3389/fimmu.2024.1342833.